Polymorphism of metalloproteinases MMP-1 and MMP-2 in risk of laryngeal cancer;Polimorfizm genów metaloproteinaz MMP-1 i MMP-2 w ocenie predyspozycji do zachorowania na raka krtani

Otolaryngologia Polska

Volumn 66, Issue 4 SUPPL., 2012, Pages 30-35

  Olejniczak, Izabela ^a   Fendler, Wojciech ^a   Borowiec, MacIej ^a   Młynarski, Wojciech ^a   Pietruszewska, Wioletta ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

extra cellular matrix; laryngeal cancer; metalloproteinases; polymorphism

Indexed keywords

GELATINASE A; INTERSTITIAL COLLAGENASE;

ARTICLE; CANCER RISK; CONTROLLED STUDY; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; LARYNX CANCER; MAJOR CLINICAL STUDY; MMP 1 GENE; MMP 2 GENE; RISK ASSESSMENT; RISK FACTOR;

ALLELES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LARYNGEAL NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; POLYMORPHISM, GENETIC; RISK ASSESSMENT; RISK FACTORS;

EID: 84869454427     PISSN: 00306657     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0030-6657(12)70782-5     Document Type: Article

References (28)

1. S.E. Bojesen, and B.G. Nordestgaard The common germline Arg72Pro polymorphism of p53 and increased longevity in humans Cell Cycle 7 2 2008 158 163 (Pubitemid 351366514)
2. J. Califano, P. Van Der Riet, W. Westra, H. Nawroz, G. Clayman, and S. Piantadosi Genetic progression model for head and neck cancer: implications for field cancerization Cancer Res 56 11 1996 2488 2492 (Pubitemid 26170679)
3. P. Rusin, Ł. Markiewicz, and I. Majsterek Uwarunkowania genetyczne nowotworów głosy i szyi Postepy Hig Med Dosw. (online) 62 2008 490 501
4. K. Szyfter Rola czynnika genetycznego w powstawaniu i przebiegu płaskonabłonkowego raka krtani Post Chir Głowy Szyi 1 1 2002 5 19
5. B. Brehmer, S. Biesterfeld, and G. Jakse Expression of matrix metalloproteinases (MMP-2 and -9) and their inhibitors (TIMP-1 and -2) in prostate cancer tissue Prostate Cancer Prostatic Dis 6 3 2003 217 222 (Pubitemid 37185149)
6. H. Nagel, R. Laskawi, A. Wahlers, and B. Hemmerlein Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1, -2, and -3 in benign and malignant tumours of the salivary gland Histopathology 44 3 2004 222 231 (Pubitemid 38406614)
7. P. Redondo, P. Lloret, M. Idoate, and S. Inoges Expression and serum levels of MMP-2 and MMP-9 during human melanoma progression Clin Exp Dermatol 30 5 2005 541 545 (Pubitemid 41076024)
8. M. Kowalski, K. Przybyłowska, P. Rusin, J. Olszewski, A. Morawiec-Sztandera, and A. Bielecka-Kowalska Genetic polymorphisms in DNA base excision repair gene XRCC1 and the risk of squamous cell carcinoma of the head and neck J Exp Clin Cancer Res 28 1 2009 37 43
9. F. Zinzindohoue, H. Blons, S. Hans, M.A. Loriot, A.M. Houllier, and D. Brasnu Single nucleotide polymorphisms in MMP1 and MMP3 gene promoters as risk factor in head and neck squamous cell carcinoma Anticancer Res 24 3b 2004 2021 2026 (Pubitemid 38954627)
10. M. Kowalski, A. Walczak, and I. Majsterek Metaloproteinazy macierzowe (MMPs) - nowoczesne markery molekularne do prognozowania i terapii jaskry otwartego ka̧ta Postepy Hig Med Dosw. (online) 62 2008 582 592
11. Y.C. Fong, C.M. Dutton, S.S. Cha, N. Garamszegi, F.H. Sim, and S.P. Scully Absence of a correlation between the presence of a singlenucleotide polymorphism in the matrix metalloproteinase 1 promoter and outcome in patients of chondrosarcoma Clin Cancer Res 10 21 2004 7329 7334 (Pubitemid 39487722)
12. B.A. Mercer, A.M. Wallace, C.E. Brinckerhoff, and J.M. D'Armiento Identification of a cigarette smoke-responsive region in the distal MMP-1 promoter Am J Respir Cell Mol Biol 40 1 2009 4 12
13. G.B. Tower, C.I. Coon, K. Belguise, D. Chalbos, and C.E. Brinckerhoff Fra-1 targets the AP-1 site/2G single nucleotide polymorphism (ETS site) in the MMP-1 promoter Eur J Biochem 270 20 2003 4216 4225 (Pubitemid 37281640)
14. K. Przybyłowska, A. Kluczna, M. Zadrozny, T. Krawczyk, A. Kulig, and J. Rykała Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer Breast Cancer Res Treat 95 1 2006 65 72 (Pubitemid 43228082)
15. Y. Zhu, M.R. Spitz, L. Lei, G.B. Mills, and X. Wu A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility Cancer Res 61 21 2001 7825 7829 (Pubitemid 33049371)
16. B. Peng, L. Cao, W. Wang, L. Xian, D. Jiang, and J. Zhao Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: a meta-analysis of 50 case-control studies Mutagenesis 25 1 2010 41 48
17. T. Hashimoto, K. Uchida, N. Okayama, Y. Imate, Y. Suehiro, and Y. Hamanaka Association of matrix metalloproteinase (MMP-1) promoter polymorphism with head and neck squamous cell carcinoma Cancer Lett 211 1 2004 19 24 (Pubitemid 38759765)
18. Z.G. Cao, and C.Z. Li A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances oral squamous cell carcinoma susceptibility in a Chinese population Oral Oncol 42 1 2006 32 38
19. S. Matsumura, N. Oue, Y. Kitadai, K. Chayama, K. Yoshida, and Y. Yamaguchi A single nucleotide polymorphism in the MMP-1 promoter is correlated with histological differentiation of gastric cancer J Cancer Res Clin Oncol 130 2004 259 265 (Pubitemid 38680266)
20. R.S. Heist, A.L. Marshall, G. Liu, W. Zhou, L. Su, and D. Neuberg Matrix metalloproteinase polymorphisms and survival in stage I non-small cell lung cancer Clin Cancer Res 12 18 2006 5448 5453 (Pubitemid 44497260)
21. T.A. O'Mara, J.A. Clements, and A.B. Spurdle The use of predictive or prognostic genetic biomarkers in endometrial and other hormone-related cancers: justification for extensive candidate gene single nucleotide polymorphism studies of the matrix metalloproteinase family and their inhibitors Cancer Epidemiol Biomarkers Prev 18 2009 2352 2365
22. C. Yu, K. Pan, D. Xing, G. Liang, W. Tan, and L. Zhang Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer Cancer Res 62 22 2002 6430 6433 (Pubitemid 35364100)
23. X. Miao, C. Yu, W. Tan, P. Xiong, G. Liang, and W. Lu A functional polymorphism in the matrix metalloproteinase-2 gene promoter (-1306C/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma Cancer Res 63 14 2003 3987 3990 (Pubitemid 36917916)
24. B. Peng, L. Cao, X. Ma, W. Wang, D. Wang, and L. Yu Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk Mutagenesis 25 4 2010 371 379
25. Y. Zhou, C. Yu, X. Miao, W. Tan, G. Liang, and P. Xiong Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase- 2 and tissue inhibitor of metalloproteinase- 2 genes Carcinogenesis 25 3 2004 399 404 (Pubitemid 38344407)
26. J.Y. Shao, Y. Cao, X.P. Miao, M.Y. Huang, L. Deng, and J.J. Hao A single nucleotide polymorphism in the matrix metalloproteinase 2 promoter is closely associated with high risk of nasopharyngeal carcinoma in Cantonese from southern China Chin J Cancer 30 9 2011 620 626
27. G. Zhou, Y. Zhai, Y. Cui, W. Qiu, H. Yang, and X. Zhang Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma Hum Mutat 28 11 2007 1091 1097 (Pubitemid 350036913)
28. S.C. Lin, S.S. Lo, C.J. Liu, M.Y. Chung, J.W. Huang, and K.W. Chang Functional genotype in matrix metalloproteinases-2 promoter is a risk factor for oral carcinogenesis J Oral Pathol Med 33 7 2004 405 409